Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
[摘要] ↵* E.H. and V.E.T. contributed equally to this report as the 156-05-002 and 156-04-250 (TEMPO42) leaders. All investigators are listed in the Appendix.
[发布日期] [发布机构]
[效力级别] [学科分类] 泌尿医学
[关键词] Bone marrow necrosis;Sickle cell disease;Hyperhemolysis syndrome [时效性]
